Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cureus|December 22, 2025
Treatment Pathways and Outcomes in Unresectable Gastric Cancer: A Retrospective Cohort AnalysisYonatan Lessing, Tal Inbar-Weissman, Ron Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2015
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trialsAndrew D Goodman, Francois Bethoux, Theodore R Brown, et al.
The American Journal of Clinical Nutrition|August 14, 2009
Differential functional magnetic resonance imaging response to food pictures in successful weight-loss maintainers relative to normal-weight and obese controlsJeanne M McCaffery, Andreana P Haley, Lawrence H Sweet, et al.
Annals of Neurology|October 27, 2010
A phase 3 trial of extended release oral dalfampridine in multiple sclerosisAndrew D Goodman, Theodore R Brown, Keith R Edwards, et al.
Lancet (London, England)|March 3, 2009
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trialAndrew D Goodman, Theodore R Brown, Lauren B Krupp, et al.
International Journal of Molecular Sciences|May 27, 2023
The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous NephropathyOlga Lesya Kukuy, Ron Cohen, Boris Gilburd, et al.
Pageof 3